Jinhe Biotech: Use 80 million yuan of idle funds raised to temporarily supplement the liquidity and return it later.

Jinhe Biosciences announced that on September 19, 2025, the company held a meeting and agreed to temporarily supplement working capital with unused funds raised, not exceeding 80 million yuan, for a period of up to 12 months. The company actually used 80 million yuan to supplement cash flow. On January 13, 2026, the company had repaid the full amount to the special account for funds raised and notified the sponsoring institution and the sponsoring representative.